This story originally ran on Nov. 18.

By Tony Fong

Despite a contraction in revenues related to its core technology, sample prep firm Pressure BioSciences this week reported a 19-percent increase in total revenues for the third quarter.

For the three months ended Sept. 30, the South Easton, Mass.-based company posted receipts of $317, 427, up from $265,662. Net loss for the quarter shrank 31 percent to $753,449, or $0.35 per share, from $1.1 million, or $0.50 per share, a year ago.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.